A detailed history of Abel Hall, LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Abel Hall, LLC holds 11,037 shares of SERA stock, worth $32,669. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,037
Previous 11,037 -0.0%
Holding current value
$32,669
Previous $30.6 Million 10.47%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 23, 2025

BUY
$1.49 - $3.46 $16,445 - $38,188
11,037 New
11,037 $30.6 Million

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $87.6M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Abel Hall, LLC Portfolio

Follow Abel Hall, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abel Hall, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abel Hall, LLC with notifications on news.